International Stem Cell Corporation is all about getting the word out there. They have announced some near future events that will help increase scientific awareness of the Company, its proprietary Parthenogenic Stem Cell Lines, and their potential uses in research and therapy.
On January 25th Kenneth Aldrich, Chairman of ISCO, will participate in two panel discussions regarding biotech funding and exit strategies at the “Cell and Gene Therapy Forum 2010” in Washington DC. On the 26th of January Brian Lundstrom, President of ISCO, will present the company and its Asian partnering opportunities in cell culture products, cornea transplantation and universal stem cells at “BIO Asia Partnering” in Tokyo. And finally the third event that the company hopes to help bring awareness will occur on February 5th and that will include a webinar on ISCO’s strategy and 2010 plans, and this will be concluded by Mr. Aldrich.
As you can see in the near future ISCO plans on getting the word out about their company and hopefully people will see the importance of ISCO.
Best Damn Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move.
Sign Up for our Free Stock Newsletter
ABOUT INTERNATIONAL STEM CELL CORPORATION (ISCO.OB):
International Stem Cell Corporation is a California-based biotechnology company focused on therapeutic and research products. ISCO’s core technology, parthenogenesis, results in creation of pluripotent human stem cells from unfertilized oocytes (eggs). ISCO scientists have created the first parthenogenic, homozygous stem cell line that can be a source of therapeutic cells with minimal immune rejection after transplantation into hundreds of millions of individuals of differing sexes, ages and racial groups. This offers the potential to create the first true stem cell bank, UniStemCell™, while avoiding the ethical issue of using fertilized eggs. ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide through its subsidiary Lifeline Cell Technology.
Sign up for the free Best Damn Penny Stocks newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website
About Best Damn Penny Stocks
Best Damn Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer
